Fairvalue-Calculator Fairvalue-Calculator
EN DE

Rezolute, Inc (RZLT) Fair Value & Analysis

Healthcare · US · Market cap $496M

Price$4.89
Fair Value$7.58
Upside+55.0%
Quality95/100
Evidence: Low Range $5.68 – $9.47

Fair value as of: Jun 24, 2026

Analysis

Rezolute, Inc (RZLT) currently trades at $4.89, while our model-based Fair Value estimate is $7.58 — implying the stock looks roughly 55.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is Rezolute, Inc (RZLT) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $7.58 versus a price of $4.89 — about +55% (undervalued). Model-based estimate, not financial advice.
What is the fair value of RZLT?
Our 21-model fair value for Rezolute, Inc is $7.58 (as of Jun 24, 2026), built from audited fundamentals. The current price is $4.89.
What is the quality score of RZLT?
Rezolute, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.